title: Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
authors.affiliation: aServicio de Hematología y Hemoterapia bUnidad VIH, Hospital Universitario La Paz-IDIPaz, Madrid cCentro Regional Hemodonación Murcia-IMIB, Hospital Morales Messeguer, Murcia, Spain.
authors.forename: María T
authors.initials: MT
authors.lastname: Álvarez-Román
authors.forename: María I
authors.initials: MI
authors.lastname: Rivas Pollmar
authors.forename: José I
authors.initials: JI
authors.lastname: Bernardino
authors.forename: María L
authors.initials: ML
authors.lastname: Lozano
authors.forename: Mónica
authors.initials: M
authors.lastname: Martín-Salces
authors.forename: Ihosvany
authors.initials: I
authors.lastname: Fernández-Bello
authors.forename: Víctor
authors.initials: V
authors.lastname: Jiménez-Yuste
authors.forename: Nora V
authors.initials: NV
authors.lastname: Butta
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D053139:Oseltamivir / Q000008:administration & dosage*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis* / Q000188:drug therapy*; D011961:Receptors, Fc / Q000008:administration & dosage*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D013926:Thrombopoietin / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D053139:Oseltamivir; D013926:Thrombopoietin; C488777:romiplostim